ArticleTherapeutic advances in medical oncology2022

CORRECTION NOTICE "Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma".

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.